Author

Giuseppe Riccardo Diaferia

Champalimaud FoundationORCID 0000-0003-4022-8483Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:large language model· 1 Approach:machine learning (classical)· 1 Approach:statistical model· 1

Frequent Co-Authors

Chakit AroraiD· 2 shared Francesco CarliiD· 2 shared Francesco RaimondiiD· 2 shared Gioacchino NatoliiD· 2 shared Luisa BiscegliaiD· 2 shared Natalia De Oliveira RosaiD· 2 shared Pierluigi Di ChiaroiD· 2 shared Alice CortesiiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Chakit AroraORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsNature CommunicationsPeer-reviewedFeb 14, 2025

Learning and actioning general principles of cancer cell drug sensitivity

Francesco Carli, Pierluigi Di Chiaro, Mariangela Morelli…·Francesco Raimondi

The paper develops interpretable models to predict cancer drug sensitivity using transcriptomics data and enhances predictions with large language models, validated on clinical samples.

38 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsCell GenomicsPeer-reviewedMay 1, 2024

The landscape of cancer rewired GPCR signaling axes

Chakit Arora, Marin Matic, Luisa Bisceglia…·Francesco Raimondi

The paper analyzes GPCR signaling dysregulation in cancer transcriptomics data to identify therapeutic targets and survival-associated signaling axes.

35 citationstop 3%

humanbulk RNA-seq

𝕏 PostBluesky